(Reuters Health) - Women who currently use or recently used hormone-based contraception face a 20 percent higher risk of breast cancer, although the overall risk for most women is relatively low, a new study of 1.8 million women in Denmark has concluded. [Source]
NEW YORK (Reuters) - Three women who have accused U.S. President Donald Trump of sexual misconduct called on Monday for a congressional investigation into his behavior amid a wave of similar accusations against prominent men in Hollywood, the media and politics.
President Donald Trump downs a dozen Diet Cokes each day, The New York Times reported this weekend. His love of the bubbly beverage is shared by many Americans and at least one of his predecessors. President Bill Clinton was frequently photographed with a can in his hand and reportedly placed a Diet Coke -- along with a now-outdated cell phone and other items -- in a time capsule at his official presidential library.
(Reuters Health) - Even though window coverings have been recognized for decades as a safety hazard to children, injuries from blinds and shades still send many kids to the emergency room each year, a U.S. study suggests.
Reuters Health - When one person in a household gets prescribed opioids, the other people who live with them are more likely to get their own prescriptions for these narcotic painkillers, a U.S. study suggests.
A group of women who have publicly accused President Donald Trump of sexual harassment and assault will detail their accounts of being groped, fondled and forcibly kissed by the businessman-turned-politician at a news conference on Monday.
LONDON (Reuters) - Scientists have for the first time fixed a protein defect that causes Huntington's disease by injecting a drug from Ionis Pharmaceuticals into the spine, offering new hope for patients with the devastating genetic disease.
LONDON (Reuters) - Scientists have for the first time fixed a protein defect that causes Huntingdon's disease by injecting a drug from Ionis Pharmaceuticals into the spine, offering new hope for patients with the devastating genetic disease.
JAKARTA (Reuters) - Health authorities in Jakarta kicked off a special immunization program on Monday to rein in an "extraordinary" outbreak of diphtheria that has sparked concerns about the Indonesian capitalâ€™s readiness to host the Asian Games next June. Diphtheria cases have spiked 42 percent since last year, health officials say, with at least 32 deaths and more than 590 cases recorded across the archipelago, the bulk of them in densely populated Jakarta and neighboring provinces.
LONDON (Reuters) - GlaxoSmithKline will scout for deal opportunities in cancer medicine, as well as immunology, as the drugmaker seeks to rebuild its presence in oncology, its new head of pharmaceuticals told Reuters.
ZURICH (Reuters) - Combining Roche's Tecentriq immunotherapy with its older drug Avastin reduced the risk of disease worsening or death (PFS) for the initial treatment of advanced kidney cancer in some patients, the Swiss drugmaker said on Monday
ZURICH, Dec 11 (Reuters) - Combining Roche's Tecentriq immunotherapy with its older drug Avastin reduced the risk of disease worsening or death (PFS) for the initial treatment of advanced kidney cancer in some patients, the Swiss drugmaker said on Monday
LOS ANGELES (Reuters) - Merck & Co Inc, maker of the only immunotherapy approved for patients newly-diagnosed with the most common type of lung cancer, could solidify its lead by playing the long game, even as rivals edge closer.
Dec 10 (Reuters) - Patients with an advanced form of an aggressive blood cancer who had initially responded to Novartis' new type of gene-modifying immunotherapy continued to respond at least six months after treatment, according to updated data released at a medical meeting on Sunday.
NEW YORK (Reuters) - Ascension Health and Providence St. Joseph Health are in talks about a merger between the two Catholic non-profits that would create the largest U.S. hospital chain, the Wall Street Journal reported on Sunday, citing people familiar with the discussions.
NEW YORK (Reuters) - Ascension Health and Providence St. Joseph Health are in discussions about a merger that would create the largest hospital chain in the United States, the Wall Street Journal reported on Sunday, citing people familiar with the situation.
MANILA (Reuters) - As she announced in January 2016 that the Philippines would immunize one million children with a new dengue vaccine, the nation's then health secretary Janette Garin boasted it was a world-first and a tribute to her country's "expertise" in research.
PARIS (Reuters) - France has ordered banned the sale and ordered a recall of several baby formula milk and baby food products made by French dairy giant Lactalis after the discovery of salmonella bacteria, consumer protection agency DGCCRF said in a statement.
(Reuters) - More than half of trial patients with an advanced, aggressive form of blood cancer lived for at least a year after one-time treatment with Yescarta, a novel therapy sold by Gilead Sciences Inc, according to study results presented on Sunday.
Dec 10 (Reuters) - More than half of patients with advanced multiple myeloma who had run out of therapeutic options remained in complete remission after receiving bluebird bio Inc's experimental gene-modifying immunotherapy in a small, early stage study, according to updated data released on Sunday.
WASHINGTON (Reuters) - U.N. Ambassador Nikki Haley said on Sunday she believes any woman who has felt violated or mistreated by a man has every right to speak up, even if it is President Donald Trump they are accusing.
(Reuters) - An experimental Roche Holding AG drug, added to standard therapy, led to a far higher rate of remission and helped patients with an advanced, aggressive blood cancer live significantly longer than the standard treatment alone, according to data from a mid-stage trial released at a medical meeting on Sunday.
Dec 10 (Reuters) - An experimental Roche Holding AG drug, added to standard therapy, led to a far higher rate of remission and helped patients with an advanced, aggressive blood cancer live significantly longer than the standard treatment alone, according to data from a mid-stage trial released at a medical meeting on Sunday.
SEOUL/UNITED NATIONS (Reuters) - The United Nations political affairs chief told senior North Korean officials during a visit to Pyongyang this week that there was an "urgent need to prevent miscalculations and open channels to reduce the risks of conflict," the world body said.
LONDON (Reuters) - U.S. congressional committee members warned on Friday that Washington's funding of the World Health Organization's cancer research agency could be halted unless it is more open about its operations.
(Reuters) - Eli Lilly & Co said on Friday a late-stage trial testing its drug, Cyramza, as a gastric cancer treatment met the main goal of preventing the disease from advancing, but failed its secondary target of improving overall survival rates.
Dec 8 (Reuters) - Eli Lilly & Co said on Friday a late-stage trial testing its drug, Cyramza, as a gastric cancer treatment met the main goal of preventing the disease from advancing, but failed its secondary target of improving overall survival rates.
(Reuters Health) - Older teens struggling with depression are more than twice as likely to drop out of high school as peers without that mental illness or those who recovered from a bout of depression earlier in life, Canadian researchers say.
LAKE LOUISE, Alberta (Reuters) - The downhill is very much a high risk, high reward business and American speed queen Lindsey Vonn was reminded again of the price you pay for success on the alpine World Cup ski circuit.
KAMPALA (Reuters) - Uganda said on Friday it had successfully contained an outbreak of the Marburg virus, a highly infectious haemorrhagic fever announced by officials on Oct. 19, which killed three people.
(Reuters) - Patients with advanced breast cancer tied to an inherited gene mutation who were treated with an experimental Pfizer Inc drug went about three months longer before their disease worsened than those who received chemotherapy in a late stage study, according to data released on Friday.
Dec 8 (Reuters) - Patients with advanced breast cancer tied to an inherited gene mutation who were treated with an experimental Pfizer Inc drug went about three months longer before their disease worsened than those who received chemotherapy in a late stage study, according to data released on Friday.
WARSAW (Reuters) - The Venice Commission, a panel of constitutional law experts of the human rights body Council of Europe, said on Friday that Poland's proposed court overhaul poses serious risks to all parts of the country's judiciary.
SAN CRISTOBAL/MARACAIBO, Venezuela (Reuters) - Venezuela's critical medicine shortage has spurred "medical flea markets," where peddlers offer everything from antibiotics to contraceptives laid out among the traditional fruits and vegetables.
MANILA (Reuters) - The Philippines will seek the return of 3 billion pesos ($59 million) it paid French drugmaker Sanofi for a dengue vaccine used to immunize hundreds of thousands of children that Sanofi has said could worsen the disease in some cases.
ZURICH (Reuters) - Scientists at Swiss drugmaker Roche said on Friday they may have discovered why some tumors resist new immunotherapy drugs as well as a possible means of turning the tables to incite a T-cell attack.
(Reuters) - The U.S. Department of Justice asked on Thursday for documents related to a Senate committee's report on the transfer of fetal tissue by abortion provider Planned Parenthood, according to a letter seen by Reuters.
(Reuters) - The U.S. Department of Justice sent a letter on Thursday, seen by Reuters, seeking documents related to a Senate committee's report on the transfer of fetal tissue by abortion provider Planned Parenthood.
CHICAGO (Reuters) - The sale and distribution of antibiotics approved for use in food-producing animals in the United States decreased by 10 percent from 2015 to 2016, a U.S. Food and Drug Administration (FDA) report said on Thursday.
On Thursday afternoon, White House press secretary Sarah Sanders was asked about Al Franken's description of President Donald Trump as "a man who has bragged on tape about his history of sexual assault."
(Reuters) - Drug developer Sage Therapeutics Inc's shares soared as much as 85 percent to a record high on Thursday after its experimental drug to reduce the symptoms of depression succeeded in a mid-stage trial.
JOHANNESBURG (Reuters) - Egg prices in South Africa are expected to increase by as much as 20 percent after an outbreak of the highly pathogenic avian flu in June forced farmers to cull egg laying birds, industry experts said on Thursday.
LONDON (Reuters) - The race to develop new immunotherapy treatments against cancer has sparked an unprecedented explosion in the oncology drug pipeline, with more than 2,000 immune system-boosting agents now in development.
BEIRUT (Reuters) - Iran's allies in Lebanon have emerged even stronger from a crisis triggered by Saudi Arabia, which achieved little more than to force the Saudis' main Lebanese ally - Prime Minister Saad al-Hariri - closer to Tehran's friends in Beirut.
(Reuters) - Sage Therapeutics Inc's shares surged more than 63 percent premarket on Thursday, on track to add about $2.5 billion to the company's market value, after its drug succeeded in reducing the symptoms of depression in a mid-stage trial.
BRIEF-Kalytera Therapeutics Says â€Results Of Phase 2 Clinical Study In Prevention Of Graft Versus Host Diseaseâ€‹ Are Expected By Q3 2018
* KALYTERA ANNOUNCES INITIATION OF PHASE 2 CLINICAL STUDY IN PREVENTION OF GRAFT VERSUS HOST DISEASE AND AGREEMENT WITH THE SALZMAN GROUP OF ISRAEL TO MANAGE AND PARTIALLY FUND THE STUDY TO BE LED BY A WORLD CLASS TEAM
BUDAPEST (Reuters) - Hungary's main opposition party would be unable to compete at an election next April if state auditors impose a heavy fine in a campaign finance case, a vice chairman for the nationalist Jobbik party told Reuters on Thursday.
(Reuters) - Sage Therapeutics Inc said on Thursday its drug to treat patients with moderate to severe depression met the main goal of reducing symptoms in a mid-stage study, sending its shares soaring 52.3 percent in premarket trading.
Dec 7 (Reuters) - Sage Therapeutics Inc said on Thursday its drug to treat patients with moderate to severe depression met the main goal of reducing symptoms in a mid-stage study, sending its shares soaring 52.3 percent in premarket trading.
JAKARTA (Reuters) - Indonesian health authorities will launch an immunization drive next week to contain a sharp rise in cases of diphtheria, which has killed at least 32 people, including many children, in the world's fourth most populous country this year.
TOKYO (Reuters) - Asian shares hovered above two-month lows on Thursday as some high-tech bellwethers bounced back after a searing sell-off although softer oil and copper prices and uncertainty over U.S. policy kept many investors cautious.
TOKYO, Dec 7 (Reuters) - Asian shares hovered above two-month lows on Thursday as some high-tech bellwethers bounced back after a searing sell-off although softer oil and copper prices and uncertainty over U.S. policy kept many investors cautious.
ZURICH, Dec 7 (Reuters) - Adding Roche's immunotherapy Tecentriq to older drugs doubled the percentage of lung cancer patients who survived a year without their disease advancing, an outcome some experts labeled unprecedented.
JOHANNESBURG, Dec 7 (Reuters) - The South African rand weakened on Thursday, as appetite for emerging market currencies globally was subdued with investors avoiding big bets ahead of employment data in the United States, seen as an indicator to the direction of interest rates.
ZURICH, Dec 7 (Reuters) - Adding Roche's immunotherapy Tecentriq to older drugs doubled the percentage of lung cancer patients who survived a year without their disease advancing, an outcome some experts labeled unprecedented.
TOKYO (Reuters) - Asian shares hovered near two-month lows on Thursday as softer oil and copper prices and uncertainty over U.S. policy kept many investors on the sidelines, even as some high-tech bellwethers bounced back after a searing sell-off.
TOKYO (Reuters) - Asian shares held close to a two-month low on Thursday as softer oil and copper as well as U.S. policy uncertainty kept sentiment in check, while high-tech stocks struggled to recover after a searing sell-off.
TOKYO, Dec 7 (Reuters) - Asian shares held close to a two-month low on Thursday as softer oil and copper as well as U.S. policy uncertainty kept sentiment in check, while high-tech stocks struggled to recover after a searing sell-off.
(Reuters Health) - Patients who live in low-income communities and lack a college education may have worse pain after knee replacement surgery than their more educated neighbors, a recent study suggests.
(Reuters Health) - Women who currently use or recently used hormone-based contraception face a 20 percent higher risk of breast cancer, although the overall risk for most women is relatively low, a new study of 1.8 million women in Denmark has concluded.
BRIEF-Novartis Says Premenopausal Women Taking Kisqali Benefited For Longer Time Until Health-Related QOL Deterioration
* NOVARTIS KISQALI IS FIRST AND ONLY CDK4/6 INHIBITOR TO SHOW SUPERIOR MEDIAN PFS COMPARED TO ORAL ENDOCRINE THERAPY AS FIRST-LINE TREATMENT IN A PROSPECTIVE, RANDOMIZED PHASE III TRIAL DEDICATED TO PREMENOPAUSAL WOMEN WITH HR+/HER2- ADVANCED BREAST CANCER
OSLO (Reuters) - World temperatures could rise 15 percent more than expected this century, obliging governments to make deeper cuts in greenhouse gas emissions to limit global warming, scientists said on Wednesday.
A little over a year ago, despite a swirl of sexual assault allegations against him and a track record of misogyny, Donald Trump beat the woman many hoped would make it to the White House -- not only to the presidency, but to the title of Time magazine's Person of the Year. This year, it is the President who has to get in line.
(Reuters) - The U.S. Food and Drug Administration issued a draft guidance on Wednesday to simplify the procedure of developing drugs for rare pediatric disorders, such as Gaucher's disease, by eliminating the need for certain trials and minimizing patient enrollment.
WASHINGTON (Reuters) - The number of people signing up for 2018 Obamacare plans picked up significantly during the fifth week of open enrollment, a U.S. government agency reported on Wednesday, but the number of people signed up for such plans appears to be falling short of last year's numbers with just over a week of enrollment left.
BANGKOK (Reuters) - A "dramatic" drop in opium cultivation in Myanmar underscored a regional boom in demand for illegal synthetic drugs such as methamphetamine, which many Asian countries are struggling to combat, a senior U.N. official said on Wednesday.
Male-pattern baldness and premature greying are associated with a greater risk of heart disease before the age of 40 than obesity, according to a new study from India. Does this mean that doctors should be screening our hairline alongside traditional risk factors such as our weight and blood pressure?
PARIS (Reuters) - Johnny Hallyday, whose death at 74 was announced by his wife and the French president on Wednesday, was a rock and roll giant in his native France and survived drug use, family strife and near-death episodes to strut the stage for more than fifty years.
PARIS (Reuters) - Johnny Hallyday, a singer known as the "French Elvis" whose cowboy swagger and gravelly voice helped popularize rock 'n roll in his country, has died at 74 after a battle with cancer, the office of the French president said on Wednesday.
PARIS (Reuters) - Johnny Hallyday, a singer known as the "French Elvis" who helped popularize rock 'n roll in his country, has died at 74 after a battle with cancer, the office of the French president said on Wednesday.
LONDON (Reuters) - Britain won a vote of confidence from its economically important life sciences sector on Wednesday as five drug companies committed to invest in the country under the government's industrial strategy plans after Brexit.
(Reuters) - The Australian Competition and Consumer Commission (ACCC) on Wednesday said it is taking local units of GlaxoSmithKline and Swiss healthcare company Novartis to court over false or misleading representations in the marketing of pain relief products.
SAO PAULO (Reuters) - Researchers have identified the molecule that attracts the insect that transmits citrus greening disease, a development expected to help farmers control a plague that has destroyed trees in growing regions of Brazil and the United States.
ASUNCION (Reuters) - Paraguay's Congress passed a bill on Tuesday creating a state-sponsored system to import marijuana seeds and grow the plant for medical uses, a decision that followed other countries in Latin America.
(Reuters Health) - Overweight and obese people who eat almonds and chocolate every day may have lower cholesterol than their counterparts who donâ€™t consume these foods, a recent experiment suggests.
(Reuters) - Galectin Therapeutics Inc said its drug for the complex progressive fatty liver disease NASH led to some clinically meaningful results in patients with cirrhosis, but failed to achieve the main goal of a mid-stage trial, sending its shares plunging 48 percent on Tuesday.
(Reuters) - Galectin Therapeutics Inc said on Tuesday its experimental drug for the complex progressive fatty liver disease NASH led to some clinically meaningful results in patients with cirrhosis, but failed to achieve the main goal of a midstage trial.
MANILA/LONDON (Reuters) - The Philippines has ordered French drugmaker Sanofi to stop the sale, distribution and marketing of its Dengvaxia dengue vaccine in the country after the company last week warned it could worsen the disease in some cases.
GENEVA (Reuters) - The World Health Organization supported a decision by the Philippines Department of Health on Tuesday to suspend vaccinations with Sanofi's dengue drug Dengvaxia, the WHO said in a statement.
WASHINGTON (Reuters) - Melting Arctic sea ice could render sun-soaked California vulnerable to a recurrence of the severe drought suffered in recent years as it is likely to cause high pressure systems that push away rain-bearing storms, a study released on Tuesday said.
Smoking cigarettes and daily use of cannabis are strongly linked in the United States, research says. Smokers, overall, are seven times more likely to use pot daily than non-smokers, according to a study recently published in the American Journal of Public Health.
LONDON, Dec 5 (Reuters) - French drugmaker Sanofi said on Tuesday the risk of severe dengue occurring in previously uninfected people given its Dengvaxia dengue vaccine was around two in 1,000 and these individuals recovered with treatment.
I am dying to know what's really going on with all the President's women. I vividly remember Ivanka Trump, in her blush-colored dress, introducing her father at the Republican National Convention in Cleveland. So compelling, so savvy -- her dress cost $138 -- and so independent.
The American opioid crisis is only part of an overall drug abuse emergency. Cocaine-related overdose deaths among non-Hispanic blacks are on par with overdose deaths caused by heroin and prescription opioids among whites, according to a study published Monday in the medical journal Annals of Internal Medicine.
(Reuters Health) - Fewer than one in 20 people with opioid addiction problems who are ordered into rehab programs by the courts receive methadone or buprenorphine, two drugs doctors consider the best treatment option, a U.S. study suggests.
(Reuters) - Montana has sued OxyContin maker Purdue Pharma LP, withdrawing from a multistate investigation by attorneys general into opioid manufacturers' marketing practices and joining a growing list of states that have broken off to pursue individual lawsuits.
(Reuters) - The World Health Organization said on Monday it hopes to review safety data on Sanofi's dengue vaccine this month, while the Philippines ordered an investigation of its now suspended massive immunization program after the French drugmaker said it could actually worsen the disease in some cases.
(Reuters Health) - Consumers are often told, "Put it in writing." But in the case of a hospitalized Florida man facing death, displaying his wish by having it tattooed on his chest wasn't good enough.
LONDON (Reuters) - Last July, Ugandan officials seized fake versions of the cancer drug Avastin on sale in Kampala, revealing only the tip of an iceberg of bogus medicines found all too often in Africa.
BRASILIA (Reuters) - The Brazilian government said on Monday it has suggested restrictions on the use of a dengue vaccine that has been suspended elsewhere after French drug company Sanofi SA said it could worsen the disease in some cases.
TEL AVIV (Reuters) - Israel's Therapix Biosciences said on Monday it expects by the end of March to have the results from its mid-stage trial of a cannabinoid-based drug for treating Tourette's syndrome which could be worth billions of dollars in revenues.
(Reuters) - Danish pharma company Alk Abello said on Monday it would invest 1 billion Danish crowns ($159 million) in its North America business, a move that is expected put a lid on earnings and revenue growth in the near term.
(Reuters) - Bangladesh plans to allocate more land for camps housing Rohingya refugees as concerns grow over a possible outbreak of disease in crowded, makeshift settlements clustered at the country's southern tip.
(Reuters) - Danish pharma company Alk Abello said on Monday it would invest about 1 billion Danish crowns ($159.5 million) over the next three years to develop its North America business and said it expected earnings to be subdued during this period.
ZURICH, Dec 4 (Reuters) - Roche on Monday said its Foundation Medicine unit won U.S. Food and Drug Administration (FDA) approval for a test to help doctors understand the genetic profile of patients' tumours and guide them to effective therapies.
GENEVA (Reuters) - Another wave of cholera could strike Yemen, where a Saudi-led coalition blockade has cut off fuel for hospitals, water pumps and vital aid supplies for starving children, the World Health Organization (WHO) said on Sunday.
MANILA (Reuters) - The office of the Philippine president on Sunday vowed to hold accountable those responsible for a suspended dengue immunization program, which it said placed thousands of lives at risk.
WASHINGTON (Reuters) - The sweeping tax overhaul that passed the U.S. Senate on Saturday contains the Republicans' biggest blow yet to former President Barack Obama's healthcare law, repealing the requirement that all Americans obtain health insurance.
(Reuters Health) - Many outcomes for hospital patients â€“ including how long they stay and their survival odds after they go home â€“ may depend on whether theyâ€™re cared for by their primary care physician or another type of doctor, a U.S. study suggests.
(Reuters) - Amgen Inc can now promote the ability of its potent but expensive cholesterol drug to reduce the risk of heart attacks and strokes, after U.S. health regulators approved adding those benefits to the medicine's prescribing label, the company said on Friday.
(Reuters) - Pharmaceutical company Sanofi SA said on Friday that it had ended development of an experimental vaccine for Clostridium difficile infection, after an early look at late-stage trial results indicated a low probability for success.
SAN FRANCISCO (Reuters) - An abrupt stock selloff on Friday, sparked by a report that magnified concerns about President Donald Trump's potential links with Russia, prompted Wall Street's favorite reaction in recent months: "Buy the dip."
LONDON/FRANKFURT (Reuters) - Swiss food giant Nestle and the private equity owners of German drug firm Stada are both preparing tentative bids for Merck KgaA's consumer health unit, several sources told Reuters.
HAVANA (Reuters) - Cuba is working on fixing chronic medicine shortages that started appearing a year ago due to its cash crunch, health officials said in an article published late on Thursday in ruling Communist Party newspaper Granma.
(Reuters) - The U.S. Food and Drug Administration on Friday approved Mylan NV's biosimilar of Herceptin, Roche's blockbuster treatment for breast cancer, making it the second copycat drug for cancer approved in the United States.
(Reuters Health) - Though most people suffering from chronic respiratory diseases want to discuss their preferences for end-of-life care with medical providers, they seldom do, a new review of past research suggests.